These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29065435)

  • 1. Graph Theoretical Analysis, In Silico Modeling, Synthesis, Anti-Microbial and Anti-TB Evaluation of Novel Quinoxaline Derivatives.
    Saravanan G; Selvam TP; Alagarsamy V; Kunjiappan S; Joshi SD; Indhumathy M; Kumar PD
    Drug Res (Stuttg); 2018 May; 68(5):250-262. PubMed ID: 29065435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
    Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A; Zarranz B; Aldana I; Monge A
    J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Zarranz B; Jaso A; Aldana I; Monge A
    Bioorg Med Chem; 2003 May; 11(10):2149-56. PubMed ID: 12713824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.
    Puratchikody A; Natarajan R; Jayapal M; Doble M
    Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel quinoxaline-alkynyl derivatives and their anti-Mycobacterium tuberculosis activity.
    Raphoko LA; Lekgau K; Lebepe CM; Leboho TC; Matsebatlela TM; Nxumalo W
    Bioorg Med Chem Lett; 2021 Mar; 35():127784. PubMed ID: 33422606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, Pharmacological Evaluation, In silico Modeling, Prediction of Toxicity and Metabolism Studies of Novel 1-(substituted)-2-methyl- 3-(4-oxo-2-phenyl quinazolin-3(4H)-yl)isothioureas.
    Sulthana MT; Alagarsamy V; Chitra K
    Med Chem; 2021; 17(4):352-368. PubMed ID: 32807063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones.
    Ramalingam P; Ganapaty S; Rao ChB
    Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.
    Wang T; Tang Y; Yang Y; An Q; Sang Z; Yang T; Liu P; Zhang T; Deng Y; Luo Y
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2084-2090. PubMed ID: 29748048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, graph theoretical analysis, density functionality theories, Insilico modeling, synthesis, characterization and biological activities of novel thiazole fused quinazolinone derivatives.
    Saravanan G; Panneerselvam T; Alagarsamy V; Kunjiappan S; Parasuraman P; Murugan I; Dinesh Kumar P
    Drug Dev Res; 2018 Sep; 79(6):260-274. PubMed ID: 30244475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity.
    Carta A; Paglietti G; Rahbar Nikookar ME; Sanna P; Sechi L; Zanetti S
    Eur J Med Chem; 2002 May; 37(5):355-66. PubMed ID: 12008050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A
    Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
    Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A
    Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of some new amide moiety bearing quinoxaline derivatives as antimicrobial agents.
    Abu Mohsen U; Yurttaş L; Acar U; Özkay Y; Kaplacikli ZA; Karaca Gencer H; Cantürk Z
    Drug Res (Stuttg); 2015 May; 65(5):266-71. PubMed ID: 24918343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, docking analysis, identification, and synthesis of novel 3-(((substituted phenyl) amino)methyl)-2-methylquinazolin-4(3H)-one compounds to fight tuberculosis.
    Panneerselvam T; Sivakumar A; Arumugam S; Joshi SD
    Drug Discov Ther; 2016; 10(4):188-94. PubMed ID: 27594295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents.
    Ahsan MJ; Samy JG; Khalilullah H; Nomani MS; Saraswat P; Gaur R; Singh A
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7246-50. PubMed ID: 22071303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
    Santivañez-Veliz M; Pérez-Silanes S; Torres E; Moreno-Viguri E
    Bioorg Med Chem Lett; 2016 May; 26(9):2188-93. PubMed ID: 27025343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-
    Palos I; Luna-Herrera J; Lara-Ramírez EE; Loera-Piedra A; Fernández-Ramírez E; Aguilera-Arreola MG; Paz-González AD; Monge A; Wan B; Franzblau S; Rivera G
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29914062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.